ARCHIVES

FDA Advisory Committee To Consider NDAs On Novantrone, HD MTX

This article is from The Cancer Letter archive.

Vol. 13 No. 46 | November 27, 1987

Download PDF Visit The Full Archive

Related Articles

Erbitux Plus Radiation, Chemo, Appears To Provide CRs In A Small Phase II Study

February 23, 2007

DCPC Advisors Begin Process Of Setting Priorities For Research

June 21, 1991

VEGF Levels Can Predict Tumor’s Resistance to Avastin

July 29, 2011

In Brief: House Hearings On NIH Budget Begin Feb. 1; Army Program Is Peer Reviewing Proposals

January 28, 1994

NCI-Approved Clinical Trials

January 26, 2007

Waksal To Pay Back $800,000 In Profits From Stock Sales

March 14, 2003